Sunovion Pharmaceuticals Canada Inc. v. Pharmascience Inc.
The Federal Court ordered a further and better affidavit of documents, required production of existing translations, and allowed limited cross-examination on the 265 Patent.
- Affidavit of documents
- Translation of foreignâlanguage documents
- Federal courts rules (rules 223,226,227,68,3)
- Proportionality in discovery
- Crossâexamination of affidavit deponent
- Costs